2.945

5.91% -0.185

Lexeo Therapeutics Inc (LXEO)

Overview News Price History Financials Discussions Forecast

Lexeo Therapeutics Inc stock is traded at $2.945, with a volume of 430.45K. It is down -5.91% in the last 24 hours and up +2.97% over the past month.

Previous Close:

$3.13

Open:

$3.08

24h Volume:

430.45K

Relative Volume:

0.93

Market Cap:

$103.91M

Revenue:

Net Income/Loss:

$-86.60M

P/E Ratio:

-1.0398

EPS:

-2.8324

Net Cash Flow:

$-67.37M

1W Performance:

-26.19%

1M Performance:

+2.97%

6M Performance:

-66.23%

1Y Performance:

-79.83%

1-Day Range:

$2.94

$3.3288

1-Week Range:

$2.90

$4.33

52-Week Range:

$2.32

$19.50

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name

Lexeo Therapeutics Inc

Sector

Healthcare (1161)

Industry

Biotechnology (676)

Phone

(212) 547-9879

Address

345 PARK AVENUE SOUTH, NEW YORK

Employee

Twitter

Next Earnings Date

2025-03-24

Latest SEC Filings

LXEO's Discussions on Twitter

Compare LXEO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LXEO Lexeo Therapeutics Inc	2.945	103.91M	0	-86.60M	-67.37M	-2.8324
VRTX Vertex Pharmaceuticals Inc	483.49	124.48B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	625.60	67.45B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	583.62	35.60B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	266.83	34.53B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	274.78	29.15B	3.81B	-644.79M	-669.77M	-6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-13-24	Initiated	Robert W. Baird	Outperform
Jun-06-24	Initiated	H.C. Wainwright	Buy
Nov-28-23	Initiated	Chardan Capital Markets	Buy
Nov-28-23	Initiated	JP Morgan	Overweight
Nov-28-23	Initiated	Leerink Partners	Outperform
Nov-28-23	Initiated	RBC Capital Mkts	Outperform
Nov-28-23	Initiated	Stifel	Buy

View All

Lexeo Therapeutics Inc Stock (LXEO) Latest News

Apr 02, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of “Buy” by Brokerages - Defense World

Apr 02, 2025

Mar 29, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stock Holdings Raised by Bank of New York Mellon Corp - Defense World

Mar 29, 2025

What is Chardan Capital’s Estimate for LXEO FY2025 Earnings? - Defense World

Mar 29, 2025

Q1 EPS Estimate for Lexeo Therapeutics Increased by Analyst - Defense World

Mar 29, 2025

Mar 28, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Lowered to $18.00 at Leerink Partners - MarketBeat

Mar 28, 2025

HC Wainwright Reaffirms Buy Rating for Lexeo Therapeutics (NASDAQ:LXEO) - Defense World

Mar 28, 2025

What is Leerink Partnrs’ Forecast for LXEO FY2025 Earnings? - Defense World

Mar 28, 2025

Mar 27, 2025

Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw? - MSN

Mar 27, 2025

Analysts Offer Predictions for LXEO Q1 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Lowered to $20.00 at Royal Bank of Canada - Defense World

Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025

H.C. Wainwright maintains Buy on Lexeo stock, $23 target By Investing.com - Investing.com Canada

Mar 26, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Receives “Buy” Rating from Chardan Capital - Defense World

Mar 26, 2025

Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's - Asianet Newsable

Mar 26, 2025

Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Sharewise

Mar 25, 2025

Why Lexeo Therapeutics (LXEO) Skyrocketed on Monday? - MSN

Mar 25, 2025

RBC Cuts Price Target on Lexeo Therapeutics to $20 From $24, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 25, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Cut to $18.00 by Analysts at Leerink Partners - Defense World

Mar 25, 2025

Lexeo Therapeutics Advances Genetic Medicine Initiatives - TipRanks

Mar 25, 2025

Mar 24, 2025

10 Small Firms Kick Off Monday with Strong Gains - Insider Monkey

Mar 24, 2025

Leerink cuts Lexeo Therapeutics price target to $18, maintains Outperform By Investing.com - Investing.com Canada

Mar 24, 2025

Lexeo Therapeutics stock soars 40% on positive trial data By Investing.com - Investing.com South Africa

Mar 24, 2025

Lexeo Therapeutics stock soars 40% on positive trial data - Investing.com India

Mar 24, 2025

Lexeo Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - MarketScreener

Mar 24, 2025

SEC Form 424B5 filed by Lexeo Therapeutics Inc. - Quantisnow

Mar 24, 2025

Lexeo Therapeutics May Offer And Sell Shares Of Common Stock Of Up To $75 MillionSEC Filing - Marketscreener.com

Mar 24, 2025